# Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

> **NCT03404674** · PHASE1 · COMPLETED · sponsor: **PATH** · enrollment: 50 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** CssBA
- **BIOLOGICAL:** dmLT

## Key facts

- **NCT ID:** NCT03404674
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03404674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03404674, "Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03404674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*